DUBLIN, April 28, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced results from an interim analysis of the first 171 patients (including 71 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback